RS

Rajesh Subhas Revankar

Active Director Director DIN 01375466
DIN 01375466 First appointment May 2001 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since May 2001
Shareholding value •••• Premium profile

About Rajesh Subhas Revankar

Data last updated:

Rajesh Subhas Revankar is a Director at Hubli Scan Centre Private Limited (since 2001), Director at Vimaleshwar Investments Private Limited (since 2006) and Managing Director at Manomay Investment Private Limited (since 2011). The companies operate in Healthcare and Financial Services. The 3 current companies with reported revenue have a combined latest revenue of ₹12.12 Cr; the largest is Hubli Scan Centre Private Limited at ₹10.86 Cr (FY 2024). Earlier, Rajesh Subhas Revankar was a Nominee Director at Suchirayu Health Care Solutions Limited (2013–2017).

DIN 01375466
Primary Designation Director
Industry Healthcare
First Appointment 28 May 2001
Oldest Company Age 25 yrs
Largest company Hubli Scan Centre Private Limited · ₹10.86 Cr (FY 2024)
Combined revenue ₹12.12 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hubli Scan Centre Private Limited U85110KA2001PTC029063
Director28 May 20012001₹10.86 Cr (FY 2024)Active
Director12 Jan 20062006₹1.25 Cr (FY 2025)Active
Manomay Investment Private Limited U74999KA2011PTC059829
Managing Director02 Aug 20112011₹15,459 (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nominee Director12 Jun 20132011₹97.77 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Vimaleshwar Investments Private Limited
Manomay Investment Private Limited
Hubli Scan Centre Private Limited
Suchirayu Health Care Solutions Limited
Premium access

Shareholding and investment profile for Rajesh Subhas Revankar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Subhas Revankar

Rajesh Subhas Revankar currently holds 3 directorships: Hubli Scan Centre Private Limited (Director, since 28 May 2001, revenue ₹10.86 Cr (FY 2024)); Vimaleshwar Investments Private Limited (Director, since 12 Jan 2006, revenue ₹1.25 Cr (FY 2025)); Manomay Investment Private Limited (Managing Director, since 02 Aug 2011, revenue ₹15,459 (FY 2025)).

Rajesh Subhas Revankar was first appointed on 28 May 2001 as Director at Hubli Scan Centre Private Limited. The most recent appointment on record is 12 Jun 2013 at Suchirayu Health Care Solutions Limited.

The 3 current companies of Rajesh Subhas Revankar that report revenue have a combined latest revenue of ₹12.12 Cr: Hubli Scan Centre Private Limited ₹10.86 Cr (FY 2024); Vimaleshwar Investments Private Limited ₹1.25 Cr (FY 2025); Manomay Investment Private Limited ₹15,459 (FY 2025).

Rajesh Subhas Revankar held 1 earlier board appointment: Suchirayu Health Care Solutions Limited (Nominee Director, 12 Jun 2013 to 01 Jul 2017).

The current boards of Rajesh Subhas Revankar's companies include Abhijit Devaraj Hiregoudar (Hubli Scan Centre Private Limited), Aniruddha Ashok Kulkarni (Hubli Scan Centre Private Limited), Chandrakant Shrikant Katwe (Hubli Scan Centre Private Limited), Dattatraya Bhaskar Nadgir (Hubli Scan Centre Private Limited), Kranthikiran Siddappa (Hubli Scan Centre Private Limited), Manojkumar Vaijanathrao Bhutte (Hubli Scan Centre Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available